National trends and outcomes of morbidly obese women who underwent inpatient hysterectomy for benign gynecological disease in the USA

2020 ◽  
Author(s):  
Koji Matsuo ◽  
Rachel S. Mandelbaum ◽  
David J. Nusbaum ◽  
Shinya Matsuzaki ◽  
Maximilian Klar ◽  
...  
Keyword(s):  
Morbidly Obese ◽  
Obese Women ◽  
The Usa ◽  
Gynecological Disease ◽  
National Trends ◽  
Benign Gynecological Disease

scholarly journals A new customised placental weight standard redefines the relationship between maternal obesity and extremes of placental size and is more closely associated with pregnancy complications than an existing population standard

2019 ◽  
Vol 11 (4) ◽  
pp. 350-359
Author(s):  
Jacqueline M. Wallace ◽  
Joeleita P. Agard ◽  
Graham W. Horgan
Keyword(s):  
Pregnancy Complications ◽  
Maternal Obesity ◽  
Population Based ◽  
Multiple Regression Model ◽  
Placental Weight ◽  
Morbidly Obese ◽  
Obese Women ◽  
Entire Cohort ◽  
Multiparous Women ◽  
The Difference

AbstractPlacental weight is a valuable indicator of its function, predicting both pregnancy outcome and lifelong health. Population-based centile charts of weight-for-gestational-age and parity are useful for identifying extremes of placental weight but fail to consider maternal size. To address this deficit, a multiple regression model was fitted to derive coefficients for predicting normal placental weight using records from healthy pregnancies of nulliparous/multiparous women of differing height and weight (n = 107,170 deliveries, 37–43 weeks gestation). The difference between actual and predicted placental weight generated a z-score/individual centile for the entire cohort including women with pregnancy complications (n = 121,591). The association between maternal BMI and placental weight extremes defined by the new customised versus population-based standard was investigated by logistic regression, as was the association between low placental weight and pregnancy complications. Underweight women had a greater risk of low placental weight [<10thcentile, OR 1.84 (95% CI 1.66, 2.05)] and obese women had a greater risk of high placental weight [>90th centile, OR 1.98 (95% CI 1.88, 2.10)] using a population standard. After customisation, the risk of high placental weight in obese/morbidly obese women was attenuated [OR 1.17 (95% CI 1.09, 1.25)]/no longer significant, while their risk of low placental weight was 59%–129% higher (P < 0.001). The customised placental weight standard was more closely associated with stillbirth, hypertensive disease, placental abruption and neonatal death than the population standard. Our customised placental weight standard reveals higher risk of relative placental growth restriction leading to lower than expected birthweights in obese women, and a stronger association between low placental weight and pregnancy complications generally. Further, it provides an alternative tool for defining placental weight extremes with implications for the placental programming of chronic disease.

Reduced FSH restraint by markedly depressed inhibin B secretion reverses after surgically induced weight loss in morbidly obese women

2008 ◽  
Vol 90 ◽  
pp. S129
Author(s):  
A.J. Polotsky ◽  
D. Rochester ◽  
A. Jain ◽  
G. Zeitlian ◽  
K. Gibbs ◽  
...  
Keyword(s):  
Weight Loss ◽  
Inhibin B ◽  
Morbidly Obese ◽  
Obese Women ◽  
Surgically Induced

scholarly journals Association between egg intake and blood pressure in the USA: the INTERnational study on MAcro/micronutrients and blood Pressure (INTERMAP)

2021 ◽  
pp. 1-9
Author(s):  
Thanh-Huyen T Vu ◽  
Linda Van Horn ◽  
Martha L Daviglus ◽  
Queenie Chan ◽  
Alan R Dyer ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Dietary Cholesterol ◽  
International Study ◽  
Obese Women ◽  
Linear Regression Models ◽  
Cross Sectional ◽  
Men And Women ◽  
The Usa ◽  
Underlying Mechanisms

Abstract Objectives: To investigate associations of egg intake with blood pressure (BP) and the role of dietary variables and other macro- and micro-nutrients in the association. Design: We used cross-sectional data for the USA as part of the INTERnational study on MAcro/micronutrients and blood Pressure (INTERMAP). INTERMAP was surveyed between 1996 and 1999, including four 24-h dietary recalls, two 24-h urine collections and eight measurements of systolic BP and diastolic BP (SBP, DBP). Average egg intake (g/d) was calculated. Multivariable linear regression models were used to estimate the association between egg intake (per each 50 g/d or per quintile) and BP. The roles of dietary variables and other macro- and micro-nutrients in this association were also investigated. Setting: In the USA. Participants: In total, 2195 US INTERMAP men and women aged 40–59 years. Results: Participants were 50 % female, 54 % non-Hispanic White and 16 % non-Hispanic Black. Mean egg intake (sd) in men and women was 30·4(29·8) and 21·6(20·5) g/d, respectively. Adjusting for demographics, socio-economics, lifestyle and urinary Na:K excretion ratios, we found non-linear associations with BP in non-obese women (P-quadratic terms: 0·004 for SBP and 0·035 for DBP).The associations remained after adjusting for dietary variables, macro/micro nutrients or minerals. Dietary cholesterol was highly correlated with egg intake and may factor in the association. No association was found in obese women and in obese or non-obese men. Conclusion: Egg intake was non-linearly associated with SBP and DBP in non-obese women, but not in obese women or men. Underlying mechanisms require additional study regarding the role of obesity and sex.

Obese and Morbidly Obese Women Have Poor Obstetric Outcomes After In Vitro Fertilization

2006 ◽  
Vol 107 (Supplement) ◽  
pp. 5S-6S
Author(s):  
Lindsey E. Baredziak ◽  
Amy Sparks ◽  
Jill Blaine ◽  
Bradley VanVoorhis ◽  
Anuja Dokras
Keyword(s):  
In Vitro Fertilization ◽  
Obstetric Outcomes ◽  
Morbidly Obese ◽  
Obese Women ◽  
Vitro Fertilization

scholarly journals Type 2 diabetes impairs pulmonary function in morbidly obese women: a case–control study

Diabetologia ◽  
2010 ◽  
Vol 53 (6) ◽  
pp. 1210-1216 ◽  
Author(s):  
A. Lecube ◽  
G. Sampol ◽  
X. Muñoz ◽  
C. Hernández ◽  
J. Mesa ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pulmonary Function ◽  
Case Control Study ◽  
Case Control ◽  
Morbidly Obese ◽  
Obese Women ◽  
Control Study

Prevalence of paradoxically normal serum cholesterol in morbidly obese women

Metabolism ◽  
2000 ◽  
Vol 49 (5) ◽  
pp. 607-610 ◽  
Author(s):  
H. Vierhapper ◽  
A. Nardi ◽  
P Grösser
Keyword(s):  
Serum Cholesterol ◽  
Normal Serum ◽  
Morbidly Obese ◽  
Obese Women

The Increase in Serum Visfatin After Bariatric Surgery in Morbidly Obese Women is Modulated by Weight Loss, Waist Circumference, and Presence or Absence of Diabetes Before Surgery

2008 ◽  
Vol 18 (8) ◽  
pp. 1000-1006 ◽  
Author(s):  
José I. Botella-Carretero ◽  
Manuel Luque-Ramírez ◽  
Francisco Álvarez-Blasco ◽  
Roberto Peromingo ◽  
José L. San Millán ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Waist Circumference ◽  
Morbidly Obese ◽  
Obese Women

Prostate-specific antigen testing in the disabled population: A cross-sectional analysis of the Health Information National Trends Survey (HINTS).

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e17000-e17000
Author(s):  
Joon Yau Leong ◽  
Ruben Pinkhasov ◽  
Thenappan Chandrasekar ◽  
Oleg Shapiro ◽  
Michael Daneshvar ◽  
...  
Keyword(s):  
Health Insurance ◽  
Health Information ◽  
Prostate Specific Antigen ◽  
Healthcare Provider ◽  
Specific Antigen ◽  
Cross Sectional ◽  
Psa Screening ◽  
Psa Testing ◽  
The Usa ◽  
National Trends

e17000 Background: Disabled patients are a unique minority population that may have lower literacy levels and difficulty communicating with physicians. Furthermore, their knowledge for cancer prevention recommendations is unknown. Herein, we aim to compare prostate-specific antigen (PSA) testing rates and associated predictors among disabled men and non-disabled men in the USA. Methods: We performed a cross-sectional study utilizing the Health Information National Trends Survey (HINTS) to analyze factors predicting PSA testing rates in men with disabilities (disabled, deaf, blind). Multivariable logistic regression models were used to determine clinically significant predictors of PSA testing in men with disabilities compared to that of the healthy cohort. Results: A total of 782 (14.6%) disabled men were compared to 4,569 (85.4%) non-disabled men. Disabled men were older with a mean age of 65.0 ± 14.2 vs. 55.0 ± 15.9 years (p < 0.001). On multivariable analysis, after adjusting for all available confounders including race, age, geographical region, survey year, marital status, health insurance, healthcare provider, amongst others, men with any disability were less likely to undergo PSA screening (OR 0.772, 95% CI 0.623-0.956, p = 0.018). Variables associated with increased PSA screening rates included age, having a healthcare provider or health insurance, and living with a partner. Although prostate cancer detection rates were shown to be higher among disabled men, this did not reach statistical significance. Conclusions: Our data suggests that significant inequalities in PSA screening exist among men with disabilities in the USA, with disabled men, especially the deaf and the blind, being less likely to be offered PSA screening. There is a clear need to implement strategies to reduce existing gaps in the care of disabled men and strive to reach equality in PSA screening in this unique population.

Sign in / Sign up

Export Citation Format

Share Document